Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00371293 · ClinicalTrials.gov registry record · NA
The Effects of Obesity and Obstructive Sleep Apnea on Inflammation and Heart Disease
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 181
- Enrollment target
NCT00371293: Completed NA study, sponsored by University of Pennsylvania.
NCT00371293 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 181 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00371293, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 181 participants
- Enrollment target
Study Summary
Obstructive sleep apnea (OSA) is a serious sleep disorder in which a person's breathing is restricted during sleep. Obese individuals with OSA are at an increased risk of inflammation and heart conditions, but it is unknown whether this risk is related to the effects of OSA or obesity. This study will evaluate whether OSA or obesity plays the primary role in inflammation related to heart disease. The study will also determine the independent effects of OSA and obesity on insulin resistance and blood vessel function.
Interventions
- DEVICE CPAP therapy
- BEHAVIORAL Weight Loss Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 181 participants |
| Start Date | 2006-09 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00371293
The ClinicalTrials.gov registry entry for NCT00371293 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 181 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CPAP therapy is the first listed.
NCT00371293 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00371293 about?
NCT00371293 is a clinical study titled "The Effects of Obesity and Obstructive Sleep Apnea on Inflammation and Heart Disease". Obstructive sleep apnea (OSA) is a serious sleep disorder in which a person's breathing is restricted during sleep. Obese individuals with OSA are at an increased risk of inflammation and heart conditions, but it is unknown whether this risk is related to the effects of OSA or obesity. This study wi...
What is the current status of trial NCT00371293?
This trial is currently completed. It is a NA study. The enrollment target is 181 participants. The study started on 2006-09. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00371293?
The interventions under investigation include: CPAP therapy (DEVICE), Weight Loss Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT00371293?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.